Amgen Inc. (AMGN)
| Previous Close | 205.82 |
| Open | 205.63 |
| Bid | 203.67 x 1000 |
| Ask | 205.64 x 1100 |
| Day's Range | 203.76 - 206.23 |
| 52 Week Range | 200.47 - 276.69 |
| Volume | |
| Avg. Volume | 2,673,449 |
| Market Cap | 117.221B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 16.90 |
| EPS (TTM) | 12.07 |
| Earnings Date | Jan. 31, 2022 - Feb. 04, 2022 |
| Forward Dividend & Yield | 7.04 (3.37%) |
| Ex-Dividend Date | Aug. 16, 2021 |
| 1y Target Est | 250.00 |
- Motley Fool
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Biopharmaceutical stocks are slated to end the year on a sour note. This industrywide sell-off has also picked up momentum during the waning days of Nov., with an eye-popping 358 biopharma stocks falling by more than 10% during just the past three weeks. Savvy investors, though, know that steep drops in the market typically represent compelling buying opportunities.
- Motley Fool
Should You Buy This Giant Biotech Stock?
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable.
- Motley Fool
2 Dividend Stocks to Buy Right Now
Second, dividend stocks have historically outperformed their peers that do not pay dividends. Two companies that would be great additions to your dividend portfolio are pharma giants Bristol Myers Squibb (NYSE: BMY) and Amgen (NASDAQ: AMGN). The company continues to post solid financial results thanks to its rich lineup of drugs.
